Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:646909.
doi: 10.1155/2014/646909. Epub 2014 Feb 17.

Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases

Affiliations
Review

Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases

Jazmin Reyes Ocampo et al. Oxid Med Cell Longev. 2014.

Abstract

The kynurenine pathway (KP) is the main route of tryptophan degradation whose final product is NAD(+). The metabolism of tryptophan can be altered in ageing and with neurodegenerative process, leading to decreased biosynthesis of nicotinamide. This fact is very relevant considering that tryptophan is the major source of body stores of the nicotinamide-containing NAD(+) coenzymes, which is involved in almost all the bioenergetic and biosynthetic metabolism. Recently, it has been proposed that endogenous tryptophan and its metabolites can interact and/or produce reactive oxygen species in tissues and cells. This subject is of great importance due to the fact that oxidative stress, alterations in KP metabolites, energetic deficit, cell death, and inflammatory events may converge each other to enter into a feedback cycle where each one depends on the other to exert synergistic actions among them. It is worth mentioning that all these factors have been described in aging and in neurodegenerative processes; however, has so far no one established any direct link between alterations in KP and these factors. In this review, we describe each kynurenine remarking their redox properties, their effects in experimental models, their alterations in the aging process.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kynurenine pathway.

References

    1. Beadle GW, Mitchell HK, Nyc JF. Kynurenine as an intermediate in the formation of nicotinic acid from tryptophane by neurospora. Proceedings of the National Academy of Sciences of the United States of America. 1947;33(6):155–158. - PMC - PubMed
    1. Moroni F, Russi P, Carla V, Lombardi G. Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neuroscience Letters. 1988;94(1-2):145–150. - PubMed
    1. Hayaishi O, Rothberg S, Mehler AH, Saito Y. Studies on oxygenases; enzymatic formation of kynurenine from tryptophan. The Journal of Biological Chemistry. 1957;229(2):889–896. - PubMed
    1. Hayaishi O. Properties and function of indoleamine 2,3 dioxygenase. Journal of Biochemistry. 1976;79(4):13P–21P. - PubMed
    1. Hirata F, Hayaishi O. Possible participation of superoxide anion in the intestinal tryptophan 2,3-dioxygenase reaction. The Journal of Biological Chemistry. 1971;246(24):7825–7826. - PubMed

Publication types